- Infectious Diseases & Outbreaks Home
- DETECT Notifiable Diseases
- TEST
- REPORT
- Case Counts
- Outbreaks
- Foodborne Diseases
- Avian Flu
- Rabies
- Waterborne Diseases
- Zoonoses
- Infection Prevention
- Meaningful Use
- Coastal Conditions
- District Investigators
- Electronic Case Reporting
- Serious Infectious Disease Network (SIDN)
- Contact Us
Case Counts
The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year.
|
|
Cases Reported Year-to-Date* |
Totals by Year Reported |
||||||
|
Condition |
2024 |
2023 |
% Change |
2023 |
2022 |
2021 |
2020 |
2019 |
|
Acute Flaccid Myelitis |
0 | 0 | -- | 0 | 2 | 1 | 0^ | 0^ |
|
Anthrax |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
|
Arboviral Diseases (excludes Chikungunya virus, Dengue, and Zika virus) |
0 | 1 | -100.0% | 32 | 5 | 12 | 10 | 6 |
|
Babesiosis |
2 | 1 | 100.0% | 1 | 0 | 1 | 1 | 4 |
|
Botulism |
0 | 0 | -- | 2 | 2 | 0 | 1 | 1 |
|
Brucellosis |
0 | 0 | -- | 1 | 0 | 1 | 1 | 4 |
|
Campylobacteriosis |
246 | 259 | -5.0% | 879 | 813 | 745 | 665 | 754 |
|
Chikungunya virus - travel related, acquired out of state |
0 | 1 | -100.0 | 1 | 0 | 0 | 0 | 0 |
|
Cholera |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
|
Coccidioidomycosis |
2 | 2 | 0.0% | 12 | 12 | 13 | 5 | 9 |
|
Cryptosporidiosis |
52 | 63 | -17.5% | 213 | 158 | 125 | 138 | 225 |
|
Cyclosporiasis |
0 | 7 | -100.0% | 140 | 19 | 6 | 9 | 4 |
|
Dengue - travel related, acquired out of state |
1 | 1 | 0.0% | 5 | 5 | 1 | 0 | 3 |
|
E. coli, shiga toxin-producing (includes O157: H7) |
33 | 43 | -23.3% | 169 | 161 | 143 | 100 | 138 |
|
Ehrlichiosis/Anaplasmosis |
1 | 0 | -- | 5 | 11 | 24 | 12 | 39 |
|
Hansen's Disease (Leprosy) |
0 | 0 | -- | 2 | 0 | 0 | 1 | 1 |
|
Hemolytic uremic syndrome (HUS) |
0 | 0 | -- | 6 | 10 | 3 | 3 | 6 |
|
Influenza-associated pediatric mortality |
1 | 1 | 0.0% | 1 | 3 | 0 | 1 | 2 |
|
Legionellosis |
17 | 15 | 13.3% | 66 | 65 | 89 | 61 | 72 |
|
Listeriosis |
1 | 4 | -75.0% | 16 | 12 | 12 | 14 | 7^ |
|
Lyme disease |
7 | 8 | -12.5% | 36 | 32 | 51 | 15 | 66 |
|
Malaria - travel related, acquired out of state |
1 | 5 | -80.0% | 11 | 8 | 8 | 2 | 9 |
|
Novel Influenza A virus infection |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
|
Paratyphoid Fever |
0 | 0 | -- | 0 | 2 | 2 | 1 | 1^ |
|
Plague |
0 | 0 | -- | 0 | 0 | 0 | 0^ | 0 |
|
Primary Amebic Meningoencephalitis (Naegleria fowleri) |
0^ |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
|
Q fever |
0 | 1 | -100.0% | 2 | 3 | 2 | 0 | 2 |
|
Rabies, animal |
7 | 12 | -41.7% | 38 | 45 | 44 | 51 | 50 |
|
Rabies, human |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
|
Salmonellosis |
152 | 167 | -9.0% | 879 | 996 | 861 | 891 | 1001 |
|
Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV) |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
|
Shigellosis |
35 | 29 | 20.7% | 100 | 81 | 88 | 346 | 433 |
|
Smallpox |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
|
Spotted Fever Rickettsiosis |
6 | 21 | -71.4% | 81 | 118 | 122 | 90 | 476^ |
|
Trichinellosis (Trichinosis) |
0 | 0 | -- | 0 | 0 | 1 | 0 | 0 |
|
Tularemia |
0 | 0 | -- | 1 | 3 | 0 | 1 | 4 |
|
Typhoid fever |
0 | 0 | -- | 2 | 0 | 3 | 1 | 0 |
|
Vibriosis (non-Cholera) |
9 | 13 | -30.8% | 37 | 41 | 34 | 26 | 41^ |
|
Viral hemorrhagic fever |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
|
VISA (Staphylococcus aureus, vancomycin-intermediate) |
0 | 0 | -- | 1 | 1 | 1 | 0 | 1 |
|
VRSA (Staphylococcus aureus, vancomycin-resistant) |
1 | 0 | -- | 0 | 0 | 1 | 1 | 2 |
|
Yellow Fever |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0^ |
|
Zika virus - travel related, acquired out of state |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
|
Other Investigations |
1 | 1 | 0.0% | 5 | 0 | 1 | 0 | 3 |
|
Total |
575 | 655 | -12.2% | 2744 | 2608 | 2395 | 2447 | 3360 |
|
NOTE: Counts include finalized investigations among Alabama residents as of May 6, 2024. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS. |
||||||||
|
*Through MMWR Week 18 (week ending May 4, 2024), as compared to the same time period in the previous calendar year. |
||||||||
|
^The case definition was updated this year for this condition. |
||||||||
Page last updated: May 7, 2024
